Dakota School of Medicine and Health Sciences, University of North, Room 118, 1919 N Elm Street, Grand Forks, ND, 58102-2416, USA.
Sanford Health, Fargo, ND, USA.
J Racial Ethn Health Disparities. 2024 Jun;11(3):1254-1259. doi: 10.1007/s40615-023-01604-7. Epub 2023 May 2.
Transcatheter aortic valve replacement (TAVR) has overtaken surgical aortic valve replacement and revolutionized the treatment strategy for aortic valve replacement. Little is known on the disparities among minorities, especially American Indians (AI), undergoing this procedure. We explore TAVR outcomes to identify disparities at our institution.
Retrospective chart review was completed on patients who underwent TAVR at a North Dakota community hospital between 2012 and 2021. There were 1133 non-AI and 20 AI patients identified (n = 1153). AI patients were identified by enrollment in nationally recognized tribes, Indian Health Service (IHS), or who self-identified as AI. Patient demographics, preoperative characteristics, procedural information, and outcomes were collected. United States 2020 census data was used for state-wide population racial percentages. Unpaired two tail t test assuming unequal variance and chi-squared tests were used to evaluate data and identify disparities between AI and non-AI.
AI presented at an earlier age (71 vs. 79; p = .001) with higher rates of diabetes (60% vs. 35%; p = .018) and history of smoking (100% vs. 60%; p ≤ .001) than Caucasian/white (C/W). The Society of Thoracic Surgery (STS) risk scores (3.2% vs. 4.6%; p = .054) and aortic valve mean gradients were lower among AI (42.8 mmHg vs. 47.5 mmHg; p = .010). For those deceased, AI had significantly shorter lifespans post-TAVR compared to C/W (374 days vs. 755 days; p = .004). AI from North Dakota had fewer TAVR procedures performed than expected (4 actual vs. 32 expected; p < .001).
AI undergoing TAVR presented earlier, with higher rates of diabetes and smoking, lower STS risk scores, and lesser aortic valve gradients than C/W. The number of TAVR procedures performed on AI from North Dakota was lower than anticipated despite a nearly 10-year period and the disparities experienced by AI who could have otherwise benefited from TAVR.
经导管主动脉瓣置换术(TAVR)已超越外科主动脉瓣置换术,并彻底改变了主动脉瓣置换术的治疗策略。对于接受该手术的少数族裔,尤其是美洲印第安人(AI),我们知之甚少。我们探讨了 TAVR 的结果,以确定我们机构的差异。
对 2012 年至 2021 年期间在北达科他州社区医院接受 TAVR 的患者进行了回顾性图表审查。共确定了 1133 名非 AI 和 20 名 AI 患者(n=1153)。AI 患者的识别依据是参加全国认可的部落、印度卫生服务部(IHS)或自我认定为 AI。收集了患者的人口统计学、术前特征、手术信息和结果。使用 2020 年美国人口普查数据计算全州人口的种族百分比。使用双尾 t 检验(假设方差不等)和卡方检验来评估数据并确定 AI 与非 AI 之间的差异。
AI 的年龄更小(71 岁 vs. 79 岁;p=0.001),糖尿病发生率更高(60% vs. 35%;p=0.018),吸烟史更高(100% vs. 60%;p≤0.001)。白人/高加索人(C/W)。胸外科医师学会(STS)风险评分(3.2% vs. 4.6%;p=0.054)和 AI 主动脉瓣平均梯度较低(42.8mmHg vs. 47.5mmHg;p=0.010)。对于死亡患者,与 C/W 相比,AI 在 TAVR 后存活时间明显更短(374 天 vs. 755 天;p=0.004)。来自北达科他州的 AI 接受的 TAVR 手术数量低于预期(实际 4 例,预期 32 例;p<0.001)。
与 C/W 相比,接受 TAVR 的 AI 年龄更小,糖尿病和吸烟率更高,STS 风险评分更低,主动脉瓣梯度更低。尽管进行了近 10 年的时间,但北达科他州 AI 的 TAVR 手术数量低于预期,这使原本可以从 TAVR 中受益的 AI 患者面临了差异。